Your browser doesn't support javascript.
loading
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.
Mosele, Fernanda; Deluche, Elise; Lusque, Amelie; Le Bescond, Loïc; Filleron, Thomas; Pradat, Yoann; Ducoulombier, Agnes; Pistilli, Barbara; Bachelot, Thomas; Viret, Frederic; Levy, Christelle; Signolle, Nicolas; Alfaro, Alexia; Tran, Diep T N; Garberis, Ingrid Judith; Talbot, Hugues; Christodoulidis, Stergios; Vakalopoulou, Maria; Droin, Nathalie; Stourm, Aurelie; Kobayashi, Maki; Kakegawa, Tomoya; Lacroix, Ludovic; Saulnier, Patrick; Job, Bastien; Deloger, Marc; Jimenez, Marta; Mahier, Celine; Baris, Vianney; Laplante, Pierre; Kannouche, Patricia; Marty, Virginie; Lacroix-Triki, Magali; Diéras, Veronique; André, Fabrice.
Afiliação
  • Mosele F; INSERM U981, Gustave Roussy, Villejuif, France.
  • Deluche E; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Lusque A; Department of Medical Oncology, CHU Dupuytren, Limoges, France.
  • Le Bescond L; Department of Biostatistics, Institut Claudius-Regaud, IUCT Oncopole, Toulouse, France.
  • Filleron T; INSERM U981, Gustave Roussy, Villejuif, France.
  • Pradat Y; CVN Lab, CentraleSupélec,Université Paris-Saclay, Gif-Sur-Yvette, France.
  • Ducoulombier A; OPIS, Inria, CentraleSupélec, Université Paris-Saclay, Gif-Sur-Yvette, France.
  • Pistilli B; Department of Biostatistics, Institut Claudius-Regaud, IUCT Oncopole, Toulouse, France.
  • Bachelot T; MICS Lab, CentraleSupélec, Université Paris-Saclay, Gif-Sur-Yvette, France.
  • Viret F; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.
  • Levy C; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Signolle N; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
  • Alfaro A; Department of Medical Oncology, Centre Paoli Calmettes, Marseille, France.
  • Tran DTN; Department of Medical Oncology, Centre François Baclesse, Caen, France.
  • Garberis IJ; AMMICa Platform, INSERM US23, CNRS UAR 3655, AMMICa, Villejuif, France.
  • Talbot H; Imaging and Cytometry Platform, Gustave Roussy, UAR 23/3655, Université Paris-Saclay, Villejuif, France.
  • Christodoulidis S; INSERM U981, Gustave Roussy, Villejuif, France.
  • Vakalopoulou M; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Droin N; CVN Lab, CentraleSupélec,Université Paris-Saclay, Gif-Sur-Yvette, France.
  • Stourm A; OPIS, Inria, CentraleSupélec, Université Paris-Saclay, Gif-Sur-Yvette, France.
  • Kobayashi M; MICS Lab, CentraleSupélec, Université Paris-Saclay, Gif-Sur-Yvette, France.
  • Kakegawa T; OPIS, Inria, CentraleSupélec, Université Paris-Saclay, Gif-Sur-Yvette, France.
  • Lacroix L; MICS Lab, CentraleSupélec, Université Paris-Saclay, Gif-Sur-Yvette, France.
  • Saulnier P; AMMICa Platform, INSERM US23, CNRS UAR 3655, AMMICa, Villejuif, France.
  • Job B; AMMICa Platform, INSERM US23, CNRS UAR 3655, AMMICa, Villejuif, France.
  • Deloger M; Translational Research Department, Daiichi Sankyo RD Novare, Tokyo, Japan.
  • Jimenez M; Translational Research Department, Daiichi Sankyo RD Novare, Tokyo, Japan.
  • Mahier C; AMMICa Platform, INSERM US23, CNRS UAR 3655, AMMICa, Villejuif, France.
  • Baris V; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Laplante P; AMMICa Platform, INSERM US23, CNRS UAR 3655, AMMICa, Villejuif, France.
  • Kannouche P; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.
  • Marty V; AMMICa Platform, INSERM US23, CNRS UAR 3655, AMMICa, Villejuif, France.
  • Lacroix-Triki M; AMMICa Platform, INSERM US23, CNRS UAR 3655, AMMICa, Villejuif, France.
  • Diéras V; R&D Department, Unicancer, Paris, France.
  • André F; R&D Department, Unicancer, Paris, France.
Nat Med ; 29(8): 2110-2120, 2023 08.
Article em En | MEDLINE | ID: mdl-37488289
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoconjugados Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoconjugados Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França